[Summary] 小分子创新药研发商
爱科诺生物医药（苏州）有限公司成立于2017年底，设立在苏州工业园区生物纳米园，是一家专注于自主研发1.1类新药（first-in-/best in ）的创新药企业。母公司为爱科诺生物医药（香港）有限公司。爱科诺生物医药首轮研发资金由晨兴创投(Morningside Venture)提供。爱科诺（苏州）主要研究方向是与调节性细胞死亡相关的分子水平的发病机制和关联靶点的成药性, 拥有丰富的产品管线。公司拥有所有项目的全球权益并已获批中国和美国专利多项。公司由国内外高端人才组成了经验丰富的专业研发和管理团队。我们致力于提高人类健康水平，振兴医药产业。
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
